Rydapt has been proven to improve survival in people with AML connected with an FLT3 mutation. Just one main study, involving 717 these kinds of people, compared Rydapt with placebo (a dummy remedy) in the beginning as an addition to other cancer medicines, accompanied by remedy with Rydapt or placebo https://johnr641inv7.tdlwiki.com/user